title: Reply to Soman et al.
authors.forename: Joel M
authors.initials: JM
authors.lastname: Dulhunty
authors.forename: Jason A
authors.initials: JA
authors.lastname: Roberts
authors.forename: Joshua S
authors.initials: JS
authors.lastname: Davis
authors.forename: Steven A R
authors.initials: SA
authors.lastname: Webb
authors.forename: Rinaldo
authors.initials: R
authors.lastname: Bellomo
authors.forename: Charles
authors.initials: C
authors.lastname: Gomersall
authors.forename: Charudatt
authors.initials: C
authors.lastname: Shirwadkar
authors.forename: Glenn M
authors.initials: GM
authors.lastname: Eastwood
authors.forename: John
authors.initials: J
authors.lastname: Myburgh
authors.forename: David L
authors.initials: DL
authors.lastname: Paterson
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Lipman
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D018805:Sepsis / Q000188:drug therapy*; D047090:beta-Lactams / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D047090:beta-Lactams